NeuroOne Announces Formation of a 6 Member Advisory Board

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

NeuroOne notes the formation of a six-member advisory board, made up of leading neurosurgeons, will assist in the completion of the development of a radiofrequency ablation electrode intended to record and ablate brain tissue linked to causing seizure activity.

The six members that have been appointed to the advisory board are as follows:

  • Dr. Daniel Couture, Wake Forest Baptist Health
  • Dr. Gerald Grant, Stanford University Medical Center
  • Dr. Bob Gross, Emory University
  • Dr. Zachary Levine, Holy Cross Health, George Washington University
  • Dr. Guy McKhann, New York Presbyterian Hospital, Columbia University
  • Dr. Jamie Van Gompel, Mayo Clinic

Dave Rosa
Dave Rosa

NeuroOne CEO Dave Rosa says, “We are honored to have an opportunity to partner with such distinguished neurosurgeons who I believe will be extremely helpful in accelerating our ablation electrode technology program. Their experience in the field will be indispensable to the Company in developing a product that allows neurologists to record brain activity and ablate targeted brain tissue in the same procedure. The electrode is also expected to save time, cost and potentially improve outcomes, adding value to both patients and physicians that could benefit from this technology.”



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.